Suppr超能文献

美国阿片类药物相关过量死亡的根本原因分析。

An analysis of the root causes for opioid-related overdose deaths in the United States.

机构信息

Lifetree Clinical Research, Salt Lake City, Utah, USA.

出版信息

Pain Med. 2011 Jun;12 Suppl 2:S26-35. doi: 10.1111/j.1526-4637.2011.01134.x.

Abstract

OBJECTIVE

A panel of experts in pain medicine and public policy convened to examine root causes and risk factors for opioid-related poisoning deaths and to propose recommendations to reduce death rates.

METHODS

Panelists reviewed results from a search of PubMed and state and federal government sources to assess frequency, demographics, and risk factors for opioid-related overdose deaths over the past decade. They also reviewed results from a Utah Department of Health study and a summary of malpractice lawsuits involving opioid-related deaths.

RESULTS

National data demonstrate a pattern of increasing opioid-related overdose deaths beginning in the early 2000s. A high proportion of methadone-related deaths was noted. Although methadone represented less than 5% of opioid prescriptions dispensed, one third of opioid-related deaths nationwide implicated methadone. Root causes identified by the panel were physician error due to knowledge deficits, patient non-adherence to the prescribed medication regimen, unanticipated medical and mental health comorbidities, including substance use disorders, and payer policies that mandate methadone as first-line therapy. Other likely contributors to all opioid-related deaths were the presence of additional central nervous system-depressant drugs (e.g., alcohol, benzodiazepines, and antidepressants) and sleep-disordered breathing.

CONCLUSIONS

Causes of opioid-related deaths are multifactorial, so solutions must address prescriber behaviors, patient contributory factors, nonmedical use patterns, and systemic failures. Clinical strategies to reduce opioid-related mortality should be empirically tested, should not reduce access to needed therapies, should address risk from methadone as well as other opioids, and should be incorporated into any risk evaluation and mitigation strategies enacted by regulators.

摘要

目的

一组疼痛医学和公共政策方面的专家召开会议,以探讨阿片类药物相关中毒死亡的根本原因和风险因素,并提出降低死亡率的建议。

方法

小组成员审查了在 PubMed 以及州和联邦政府资源中搜索的结果,以评估过去十年中与阿片类药物相关的过量死亡的频率、人口统计学和风险因素。他们还审查了犹他州卫生部研究的结果和涉及阿片类药物相关死亡的医疗事故诉讼摘要。

结果

国家数据表明,自 21 世纪初以来,与阿片类药物相关的过量死亡呈上升趋势。注意到与美沙酮相关的死亡比例很高。尽管美沙酮在开出的阿片类药物处方中不到 5%,但全国有三分之一与阿片类药物相关的死亡涉及美沙酮。小组确定的根本原因是由于知识缺陷导致的医生失误、患者不遵守规定的药物治疗方案、意外的医疗和精神健康合并症,包括物质使用障碍,以及要求美沙酮作为一线治疗的支付者政策。所有与阿片类药物相关的死亡的其他可能原因是存在其他中枢神经系统抑制剂药物(如酒精、苯二氮䓬类和抗抑郁药)和睡眠呼吸紊乱。

结论

阿片类药物相关死亡的原因是多因素的,因此解决方案必须解决处方者行为、患者促成因素、非医疗使用模式和系统故障。减少阿片类药物相关死亡率的临床策略应经过实证检验,不应减少对所需治疗的获取,应解决美沙酮和其他阿片类药物的风险,并且应纳入监管机构制定的任何风险评估和缓解策略中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验